NCT01194245: Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus |
|
|
| Completed | 2 | 135 | US | Insulin lispro, Humalog, recombinant human hyaluronidase PH20, Hylenex, rHuPH20, PH20, Insulin aspart, Insulin glulisine, Apidra, Insulin glargine, Lantus | Halozyme Therapeutics | Diabetes Mellitus, Type 1 | 08/11 | 08/11 | | |
